4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0001140361-17-026273
President and CEO sold 4,481 shares at $15.00 ($67,215)
- President and CEO acquired 4,481 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
McCarthy Sean A. · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-06-26 | Exercise or conversion : show line 1 in the form | +4,481 | $0.95 | $4,235 | 8,726 | D |
| 2017-06-26 | Sale : show line 2 in the form | +4,481 | $15.00 | $67,215 | 4,245 | D |
| Open-market sales · 4,481 sh · avg $15.00 · $67,215 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-06-26 | Exercise or conversion : show line 3 in the form Stock Option (right to buy) | −4,481 | 63,291 | D |
Loading xslF345X03/doc1.xml…